Hillsdale Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-140
| Closed | -$18.5K | – | 714 |
|
|
2025
Q3 | $18.5K | Hold |
140
| – | – | ﹤0.01% | 521 |
|
|
2025
Q2 | $14.9K | Sell |
140
-6,800
| -98% | -$739K | ﹤0.01% | 508 |
|
|
2025
Q1 | $862K | Hold |
6,940
| – | – | 0.04% | 266 |
|
|
2024
Q4 | $855K | Buy |
6,940
+300
| +5% | +$35.4K | 0.04% | 262 |
|
|
2024
Q3 | $740K | Buy |
6,640
+1,000
| +18% | +$110K | 0.06% | 289 |
|
|
2024
Q2 | $602K | Buy |
5,640
+1,685
| +43% | +$185K | 0.05% | 281 |
|
|
2024
Q1 | $476K | Sell |
3,955
-50
| -1% | -$6.13K | 0.04% | 326 |
|
|
2023
Q4 | $493K | Buy |
4,005
+25
| +0.6% | +$3.12K | 0.04% | 305 |
|
|
2023
Q3 | $515K | Buy |
3,980
+700
| +21% | +$93.3K | 0.05% | 257 |
|
|
2023
Q2 | $407K | Hold |
3,280
| – | – | 0.04% | 291 |
|
|
2023
Q1 | $480K | Hold |
3,280
| – | – | 0.04% | 320 |
|
|
2022
Q4 | $523K | Hold |
3,280
| – | – | 0.04% | 322 |
|
|
2022
Q3 | $438K | Buy |
+3,280
| New | +$499K | 0.04% | 359 |
|
|
2021
Q2 | – | Sell |
-3,550
| Closed | -$583K | – | 614 |
|
|
2021
Q1 | $583K | Sell |
3,550
-50
| -1% | -$8.23K | 0.05% | 320 |
|
|
2020
Q4 | $595K | Buy |
+3,600
| New | +$536K | 0.06% | 294 |
|
|
2020
Q1 | – | Sell |
-60
| Closed | -$9K | – | 631 |
|
|
2019
Q4 | $9K | Hold |
60
| – | – | ﹤0.01% | 495 |
|
|
2019
Q3 | $8K | Hold |
60
| – | – | ﹤0.01% | 512 |
|
|
2019
Q2 | $9K | Buy |
+60
| New | +$8.06K | ﹤0.01% | 500 |
|
|
2018
Q4 | – | Sell |
-300
| Closed | -$50K | – | 615 |
|
|
2018
Q3 | $50K | Hold |
300
| – | – | 0.01% | 299 |
|
|
2018
Q2 | $52K | Hold |
300
| – | – | 0.01% | 319 |
|
|
2018
Q1 | $45K | Hold |
300
| – | – | 0.01% | 306 |
|
|
2017
Q4 | $40K | Hold |
300
| – | – | 0.01% | 318 |
|
|
2017
Q3 | $44K | Hold |
300
| – | – | 0.01% | 320 |
|
|
2017
Q2 | $47K | Hold |
300
| – | – | 0.01% | 313 |
|
|
2017
Q1 | $44K | Hold |
300
| – | – | 0.01% | 309 |
|
|
2016
Q4 | $33K | Hold |
300
| – | – | 0.01% | 316 |
|
|
2016
Q3 | $36K | Hold |
300
| – | – | 0.01% | 342 |
|
|
2016
Q2 | $42K | Buy |
+300
| New | +$44.2K | 0.01% | 355 |
|
|
2015
Q3 | – | Sell |
-200
| Closed | -$35K | – | 519 |
|
|
2015
Q2 | $35K | Sell |
200
-400
| -67% | -$71.8K | 0.01% | 454 |
|
|
2015
Q1 | $104K | Sell |
600
-100
| -14% | -$17.2K | 0.03% | 395 |
|
|
2014
Q4 | $115K | Hold |
700
| – | – | 0.03% | 372 |
|
|
2014
Q3 | $112K | Sell |
700
-2,902
| -81% | -$446K | 0.04% | 375 |
|
|
2014
Q2 | $530K | Hold |
3,602
| – | – | 0.12% | 95 |
|
|
2014
Q1 | $500K | Sell |
3,602
-2,750
| -43% | -$414K | 0.14% | 97 |
|
|
2013
Q4 | $804K | Sell |
6,352
-50
| -0.8% | -$5.17K | 0.24% | 62 |
|
|
2013
Q3 | $589K | Sell |
6,402
-50
| -0.8% | -$4.03K | 0.18% | 76 |
|
|
2013
Q2 | $443K | Buy |
+6,452
| New | +$394K | 0.15% | 89 |
|
Other funds holding JAZZ
EC
Hillsdale Investment Management's JAZZ Position: Q4 2025 in Review
Hillsdale Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 140 shares — an estimated $18.5K sold.
Hillsdale Investment Management first reported a position in JAZZ in Q2 2013 and held it in 37 quarters. The position peaked at $862K in Q1 2025. 573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.
- Hillsdale Investment Management reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Hillsdale Investment Management sold 140 Jazz Pharmaceuticals shares in Q4 2025, an estimated $18.5K.
- Hillsdale Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 37 quarters.
- Hillsdale Investment Management's Jazz Pharmaceuticals position peaked at $862K in Q1 2025.
- 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.
Based on Hillsdale Investment Management's 13F filing for Q4 2025, filed 10 Feb 2026.